Study links metals imbalance with Alzheimer’s
03 September, 2010 by David BinningScientists from Australia and the US have published the results of a study linking an imbalance of metals in the brain with Alzheimer's disease.
New protein points to possible Alzheimer’s cure
02 September, 2010 by David BinningAn 84-year old American Nobel Laureate has discovered a new protein which observers are saying may herald a completely new approach to treating Alzheimer’s disease.
Bionomics anxiety drug could be more effective than valium
31 August, 2010 by Staff WritersAdelaide biotech Bionomics has presented the results of preclinical and clinical data for its anti-anxiety compound BNC210, demonstrating that the drug is more effective in treating stressed rats than the current market leader valium (Diazapem).
Under-arm license delivers maiden FY profit for Acrux
27 August, 2010 by Staff WritersTestosterone booster Acrux this week stormed into the black for the first time, announcing a net profit of $46.6 million after earlier in the year signing one of the biggest ever multinational licensing deals for an Australian biotech.
Feature: Fighting cancer with proteomics
19 August, 2010 by Fiona WylieWho would have thought that a staid structural part of the cell could be so treacherous in cancer, determining life or death? Maria Kavallaris at Children’s Cancer Institute Australia is using a mixture of proteomics and good old-fashioned biology to fight such treachery head-on.
Specialised Therapeutics announces success of compassionate cancer program
18 August, 2010 by David BinningA compassionate program run by Melbourne biotech Specialised Therapeutics (STA) has helped more than 240 Australian cancer patients to benefit from a world-leading new treatment based on nanoparticles, the company said.
Study sheds new light on relationship between obesity and diabetes
17 August, 2010 by Staff WritersScientists at the Walter and Eliza Hall Institute (WEHI) have completed a study showing that cells which lead to inflammation in fat tissue may be a primary cause of insulin resistance in sufferers of diabetes.
Mesoblast progressing towards Phase III bone marrow trial in US
16 August, 2010 by Staff WritersRegenerative medicine specialists Mesoblast today announced that it has provided market guidance to the FDA regarding its Phase 3 bone marrow transplantation program, which it hopes will create more options for patients as well as a reduction in incidences of graft-versus-host disease (GVHD).
Feature: Xenotransplantation offers hope to diabetes sufferers
16 August, 2010 by Fiona WylieBack when Living Cell Technologies's (LCT) current Medical Director and Founder, Professor Bob Elliott, was working in his Auckland clinic, he decided that the treatments available for patients with Type I diabetes simply weren't good enough.
New study to turn cancer research on its head
02 August, 2010 by David BinningResearchers at the Walter and Eliza Hall Institute (WEHI) have shown that programmed cell death or apoptosis, a process which has typically been assumed to prevent or slow the development of cancer, may in some instances contribute to its spreading.
Link between HIV drugs and heart attack
30 July, 2010 by David BinningA study by Sydney researchers showing that the protease inhibitor type of HIV drugs carry a greater risk of heart attack than the new integrase inhibitor family of drugs is expected to have major implications for the future direction of treatment.
WAIMR to fund two new melanoma projects
30 July, 2010 by Staff WritersThe Western Australian Institute for Medical Research (WAIMR) has awarded grants of $75,000 each to two of its scientists hoping to identify new treatments for melanoma as well as boost the effectiveness of chemotherapy drugs against the disease.
Study shows antibiotics could help fight malaria
29 July, 2010 by David BinningIn a major breakthrough for malaria treatment European researchers have shown that mice infected with the disease administered antibiotics developed immunity against re-infection.
First glimpse into Cancer Genome Project
23 July, 2010 by David BinningInitial data from the world’s largest ever study correlating the genes of cancer sufferers with their responses to medications have been released indicating the potential for promising future treatments.
New treatment for Type 2 diabetes
23 July, 2010 by Staff WritersScientists from Sydney’s Garvan Institute have demonstrated that the drug candidate Lisofylline may be useful in the treatment of Type 2 diabetes.
